Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Ellis (NPI 1720056823)

Field	Value
Entity Type	Individual
Organization	Robert Ellis
Address	3850 S National Ave
City	Springfield
State	MO
ZIP	65807
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	March 14, 2006

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

ROBERT ELLIS is a hematology & oncology physician with a long Medicare enrollment history, having an NPI enumerated since 2006-03-14 (~20 years ago). This tenure suggests an established practice footprint in Springfield, MO and a sustained Medicare billing relationship over roughly two decades. The provider’s Medicare activity appears to be the primary payer relationship recorded: total Medicare revenue is $1.5M while there is no Medicaid billing on file, indicating an effectively single-payer (Medicare) revenue profile.

Revenue concentration is high and concentrated in a small set of drug administration codes: the precomputed top 3 Medicare codes account for 83.8% of the provider's total Medicare revenue. The three dominant codes are J9144 ($595.1K, 40.1% of revenue), J9271 ($567.6K, 38.3% of revenue), and J0897 ($79.9K, 5.4% of revenue), which together indicate that injectable cancer therapies drive the vast majority of billings.

The procedure mix and top codes indicate this practice primarily operates as an oncology infusion site focused on high-cost biologic/antineoplastic injections. J9144 (daratumumab hyaluronidase) and J9271 (pembrolizumab) are high-revenue infusion/immunotherapy agents; heavy volume on these codes alongside chemotherapy administration codes (96413, 96401, add-on infusion codes) and infusion-related services (96365, 96367, 96375) is consistent with a clinic delivering regular outpatient cancer treatment and supportive oncology care.

Competitive standing on the two largest drug codes is mixed: for J9144 the provider ranks #85 of 615 nationally (86th percentile), indicating above-typical national volume but not dominant; for J9271 the provider ranks #831 of 1841 (54th percentile), which is near the middle of national peers for pembrolizumab billing. For J0897 the provider ranks #3179 of 10057 (68th percentile), a modestly above-typical position. Overall, these rank positions portray the provider as a regional/moderate-volume oncology infusion provider rather than a national leader.

Evaluation and management (E/M) billing shows relatively high utilization of mid-level office visits: 99213 accounts for 872 claims and $53.2K (3.6% of Medicare revenue) and ranks in the 98th percentile nationally for claim volume on that code (notably above typical national volume). Elevated volume for 99213 alongside a meaningful number of 99214 and 99215 visits suggests the practice maintains a steady outpatient clinic workload managing established oncology patients in addition to infusion services.

Lab and supportive service billing is present but limited in revenue share: 85025 (CBC) and 80053 (CMP) together contribute under 1% each, reflecting onsite or ordered routine labs associated with chemotherapy management rather than a laboratory-revenue center. Ancillary infusion/administration codes such as 96413 (chemotherapy administration) and infusion add-ons (96417, 96411, 96415) show typical-to-above-typical national percentiles, reinforcing that drug administration — not lab or non-oncology office care — is the core revenue engine.

From a payer mix and market-risk perspective, absence of any Medicaid billing on file means this provider is effectively single-payer Medicare-dependent in the available data. That creates exposure to Medicare reimbursement changes for oncology drugs and associated administration fees, since J9144 and J9271 alone make up the majority of revenue. Analysts should note limited diversification by payer in public claims data when evaluating financial resilience.

Statistical outlier signals are modest: the 99213 code is flagged as "notably above typical" and indeed ranks in the 98th percentile, indicating unusually high outpatient E/M claim volume relative to national peers and suggesting robust clinic visit throughput. By contrast, most high-revenue drug codes are described as "typical, unremarkable volume" or mid-percentile, so while revenue concentration is high, the drug-code volumes themselves are not extreme outliers nationally.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

44 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	15,660	$40	$595.1K
J9271	Injection, pembrolizumab, 1 mg	13,200	$40	$567.6K
J0897	Injection, denosumab, 1 mg	4,440	$20	$79.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	870	$60	$53.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	480	$90	$43.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	350	$90	$30.5K
M0010	Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services	290	$70	$19.9K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	1,610	$10	$12.9K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	80	$130	$10.9K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	80	$130	$10.3K

Showing 1–10 of 44

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 44 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Robert Ellis — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

44 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	13	40	9,100	$40	$502K
J9144	1	20	7,200	$40	$308.4K
J0897	49	210	2,400	$20	$82.4K
96413	29	160	140	$100	$19.1K
J9217	47	70	100	$130	$17.7K
J3490	19	80	40	$150	$14K
J0185	7	10	9,490	$1	$14K
99214	761	8,960	100	$80	$13.9K
99232	3,119	4,320	90	$60	$10.8K
99213	102	8,730	70	$50	$7K

Showing 1–10 of 44

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Ellis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Wilfredo Blasini	FL	Clinical Pathology Physician	$16.9M	$307.9K
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
American Oncology Partners PA	OH	Hematology & Oncology Physician	$0	$11.8M
Robert Mcdonald	AZ	Diagnostic Radiology Physician	$7.5M	$0
David Smith	MD	Hematology & Oncology Physician	$6.4M	$0
Stephen Divers	AR	Hematology & Oncology Physician	$3.9M	$1.5K
Robert Muldoon	AR	Hematology & Oncology Physician	$3.2M	$0
Bradley Sumrall	GA	Medical Oncology Physician	$3.1M	$0
Linda Hendricks	GA	Specialist	$3.1M	$0

Nearby Providers

Other providers in the same ZIP code as Robert Ellis, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Supported Living And Employment Services, Inc.	MO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$276.6M
Easy Living Inc.	MO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$183.2M
Lester E Cox Medical Centers	MO	General Acute Care Hospital	$0	$112.3M
Healthcare Services Of The Ozarks, Inc	MO	Home Health Agency	$0	$60.3M
Mercy Clinic Springfield Communities	MO	Family Medicine Physician	$0	$51.5M
Abilities First	MO	Case Management Agency	$0	$45.8M
Southwest Center For Independent Living	MO	In Home Supportive Care Agency	$0	$45.3M
Lester E Cox Medical Centers	MO	Land Ambulance	$0	$25.8M
Seniorage Area Agency On Aging	MO	Case Management Agency	$0	$19.2M
Maxim Healthcare Services, Inc.	MO	Home Health Agency	$0	$17.7M

Robert Ellis — Billing Profile & Reimbursement Data

Sign up for Robert Ellis — Billing Profile & Reimbursement Data policy alerts

Robert Ellis — Billing Profile & Reimbursement Data

Sign up for Robert Ellis — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References